GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Cash, Cash Equivalents, Marketable Securities

Dr. Lal PathLabs (NSE:LALPATHLAB) Cash, Cash Equivalents, Marketable Securities : ₹9,426 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Cash, Cash Equivalents, Marketable Securities?

Dr. Lal PathLabs's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 (₹9,295.00 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹9,425.95 Mil).

Dr. Lal PathLabs's annual cash, cash equivalents, marketable securities increased from Mar. 2022 (₹6,816.55 Mil) to Mar. 2023 (₹8,143.07 Mil) and increased from Mar. 2023 (₹8,143.07 Mil) to Mar. 2024 (₹9,425.95 Mil).


Dr. Lal PathLabs Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Dr. Lal PathLabs's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Cash, Cash Equivalents, Marketable Securities Chart

Dr. Lal PathLabs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,317.44 9,840.25 6,816.55 8,143.07 9,425.95

Dr. Lal PathLabs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,143.07 - 9,295.00 - 9,425.95

Dr. Lal PathLabs Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Dr. Lal PathLabs  (NSE:LALPATHLAB) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Dr. Lal PathLabs Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines